Literature DB >> 24892618

Synthetic dural graft septoplasty in epistaxis from hereditary hemorrhagic telangiectasia.

Wilfred Burckhardt B1, Claudia Patricia Guerra1.   

Abstract

It is an autosomal dominant vascular disorder, which has a variety of clinical manifestations, with epistaxis being one of the most common. Many treatment options exist for epistaxis, but with no consensus on which is the method of choice. We describe the case of a patient with hereditary hemorrhagic telangiectasia (HHT) secondary epistaxis with septoplasty managed with synthetic hard graft, which improved intensity and frequency of bleeding episodes. This technique is a variant of the septodermoplasty described by several authors, but the use of synthetic dura can help in obtaining better results and avoid taking skin grafts from other sites different from the surgical site.

Entities:  

Keywords:  arteriovenous malformation; epistaxis; graft; hemorrhagic telangiectasia; hereditary; septoplasty; synthetic dura

Year:  2013        PMID: 24892618      PMCID: PMC4002040     

Source DB:  PubMed          Journal:  Colomb Med (Cali)        ISSN: 0120-8322


  7 in total

1.  Epistaxis in patients with hereditary hemorrhagic telangiectasia treated with selective arterial embolization.

Authors:  Piotr Trojanowski; Tomasz Jargiello; Agnieszka Trojanowska; Janusz Klatka
Journal:  Acta Radiol       Date:  2011-08-04       Impact factor: 1.990

2.  The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study.

Authors:  Sinan Dheyauldeen; Michael Abdelnoor; Gregor Bachmann-Harildstad
Journal:  Am J Rhinol Allergy       Date:  2011 Jul-Aug       Impact factor: 2.467

3.  Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.

Authors:  Corinna G Levine; Douglas A Ross; Katharine J Henderson; Steven B Leder; Robert I White
Journal:  Otolaryngol Head Neck Surg       Date:  2008-06       Impact factor: 3.497

4.  Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series.

Authors:  H Joshi; B A Woodworth; A S Carney
Journal:  J Laryngol Otol       Date:  2011-08-16       Impact factor: 1.469

5.  Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia.

Authors:  Gita Jørgensen; Bibi Lange; Jens Højberg Wanscher; Anette Drøhse Kjeldsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-06-26       Impact factor: 2.503

Review 6.  A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT).

Authors:  Roberto Zarrabeitia; Virginia Albiñana; Matilde Salcedo; B Señaris-Gonzalez; Jose-Luis Fernandez-Forcelledo; Luisa-Maria Botella
Journal:  Curr Vasc Pharmacol       Date:  2010-07       Impact factor: 2.719

Review 7.  Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis.

Authors:  Jamie McDonald; Pinar Bayrak-Toydemir; Reed E Pyeritz
Journal:  Genet Med       Date:  2011-07       Impact factor: 8.822

  7 in total
  2 in total

1.  Partial glossectomy and floor of mouth (FOM) defect repair with biological dural graft: A case report.

Authors:  Khalid B Al-Ghamdi; Zainab A Bakhsh
Journal:  Int J Surg Case Rep       Date:  2015-04-29

2.  Application of COMPONT Medical Adhesive Glue for Tension-Reduced Duraplasty in Decompressive Craniotomy.

Authors:  Yujia Zhou; Gesheng Wang; Jialin Liu; Yong Du; Lei Wang; Xiaoyong Wang
Journal:  Med Sci Monit       Date:  2016-10-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.